Intellia Therapeutics, Inc. Common Stock (NASDAQ: NTLA) last traded at $12.84, up 3.22% on the session. The quote above updates while this page is open; the figures below are drawn from Intellia Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Intellia Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker NTLA. Its market capitalisation is $1.80 billion.
Valuation measures for Intellia Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.80B |
|---|---|
| Enterprise value | $1.82B |
| Price / sales | 30.24 |
| Price / book | 2.47 |
| Beta | 2.32 |
Trailing-twelve-month figures tagged in Intellia Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $59.51M |
|---|---|
| Net income (TTM) | -$399.98M |
| EPS (TTM) | -$3.34 |
| Operating margin | -711.66% |
| Return on equity | -54.96% |
| Cash | $106.13M |
Range and volume for NTLA over the past 52 weeks.
| 52-week high | $28.25 |
|---|---|
| 52-week low | $7.95 |
| Volume | 3.25M |
| Average volume | 4.94M |
| Previous close | $12.44 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.